{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T04:37:50Z","timestamp":1764304670266,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:00:00Z","timestamp":1641686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:00:00Z","timestamp":1641686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s12288-021-01517-7","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T10:02:42Z","timestamp":1641722562000},"page":"596-600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patients with Classical Hodgkin Lymphoma with Less Than 10.5 CD20-Positive Reed\u2013Sternberg Cells in 10 High-Power Fields Have Better Prognosis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8343-7085","authenticated-orcid":false,"given":"Dominique Fonseca Rodrigues","family":"Lacet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano Claudino","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,9]]},"reference":[{"key":"1517_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-12505-3","volume-title":"Hodgkin lymphoma: a comprehensive overview","author":"A Engert","year":"2020","unstructured":"Engert A, Younes A (2020) Hodgkin lymphoma: a comprehensive overview, 3rd edn. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-319-12505-3","edition":"3"},{"issue":"11","key":"1517_CR2","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.7150\/jca.13107","volume":"6","author":"D Benharroch","year":"2015","unstructured":"Benharroch D, Nalbandyan K, Lazarev I (2015) CD20 over-expression in Hodgkin-Reed-Sternberg cells of classical Hodgkin lymphoma: the neglected quest. J Cancer 6(11):1155. https:\/\/doi.org\/10.7150\/jca.13107","journal-title":"J Cancer"},{"issue":"4","key":"1517_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1046\/j.1365-2559.2000.00830.x","volume":"36","author":"K Watanabe","year":"2000","unstructured":"Watanabe K, Yamashita Y, Nakayama A, Hasegawa Y, Kojima H, Nagasawa T et al (2000) Varied B-cell immunophenotypes of Hodgkin\/Reed-Sternberg cells in classic Hodgkin\u2019s disease. Histopathology 36(4):353\u2013361. https:\/\/doi.org\/10.1046\/j.1365-2559.2000.00830.x","journal-title":"Histopathology"},{"issue":"5","key":"1517_CR4","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1200\/JCO.2002.20.5.1278","volume":"20","author":"GZ Rassidakis","year":"2002","unstructured":"Rassidakis GZ, Medeiros LJ, Viviani S, Bonfante V, Nadali G-P, Vassilakopoulos TP et al (2002) CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin\u2019s disease: associations with presenting features and clinical outcome. J Clin Oncol 20(5):1278\u20131287. https:\/\/doi.org\/10.1200\/JCO.2002.20.5.1278","journal-title":"J Clin Oncol"},{"issue":"11","key":"1517_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/01.MP.0000093627.51090.3F","volume":"16","author":"A Tzankov","year":"2003","unstructured":"Tzankov A, Zimpfer A, Pehrs A-C, Lugli A, Went P, Maurer R et al (2003) Expression of B-cell markers in classical Hodgkin lymphoma: a tissue microarray analysis of 330 cases. Modern Pathol 16(11):1141\u20131147. https:\/\/doi.org\/10.1097\/01.MP.0000093627.51090.3F","journal-title":"Modern Pathol"},{"issue":"4","key":"1517_CR6","first-page":"1381","volume":"9","author":"A Tzankov","year":"2003","unstructured":"Tzankov A, Krugmann J, Fend F, Fischhofer M, Greil R, Dirnhofer S (2003) Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases. Clin Cancer Res 9(4):1381\u20131386","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1517_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1365-2141.2004.04964.x","volume":"125","author":"CS Portlock","year":"2004","unstructured":"Portlock CS, Donnelly GB, Qin J, Straus D, Yahalom J, Zelenetz A et al (2004) Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin\u2019s disease. Br J Haematol 125(6):701\u2013708. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.04964.x","journal-title":"Br J Haematol"},{"issue":"11","key":"1517_CR8","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1080\/10428190802239170","volume":"49","author":"V Aldred","year":"2008","unstructured":"Aldred V, Vassallo J, Froes M, Campos AHJ, Augusto Soares F (2008) CD20 expression by Hodgkin\u2013Reed\u2013Sternberg cells in classical Hodgkin lymphoma is related to reduced overall survival in young adult patients. Leukemia Lymphoma 49(11):2198\u20132202. https:\/\/doi.org\/10.1080\/10428190802239170","journal-title":"Leukemia Lymphoma"},{"issue":"7","key":"1517_CR9","doi-asserted-by":"publisher","first-page":"e6341","DOI":"10.1371\/journal.pone.0006341","volume":"4","author":"D Canioni","year":"2009","unstructured":"Canioni D, Deau-Fischer B, Taupin P, Ribrag V, Delarue R, Bosq J et al (2009) Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases. PLoS ONE 4(7):e6341. https:\/\/doi.org\/10.1371\/journal.pone.0006341","journal-title":"PLoS ONE"},{"issue":"7","key":"1517_CR10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/pin.12175","volume":"64","author":"AA Elsayed","year":"2014","unstructured":"Elsayed AA, Asano N, Ohshima K, Izutsu K, Kinoshita T, Nakamura S (2014) Prognostic significance of CD 20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study. Pathol Int 64(7):336\u2013345. https:\/\/doi.org\/10.1111\/pin.12175","journal-title":"Pathol Int"},{"issue":"3","key":"1517_CR11","first-page":"ELT17","volume":"87","author":"J Vassallo","year":"2002","unstructured":"Vassallo J, Metze K, Traina F, de Souza CA, Lorand-Metze I (2002) Further remarks on the expression of CD20 in classical Hodgkin\u2019s lymphomas. Haematologica 87(3):ELT17","journal-title":"Haematologica"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-021-01517-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12288-021-01517-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-021-01517-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T03:44:03Z","timestamp":1655783043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12288-021-01517-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,9]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1517"],"URL":"https:\/\/doi.org\/10.1007\/s12288-021-01517-7","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"type":"print","value":"0971-4502"},{"type":"electronic","value":"0974-0449"}],"subject":[],"published":{"date-parts":[[2022,1,9]]},"assertion":[{"value":"7 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Clinical Hospital of Botucatu Medical School (HC-FMB-UNESP) research ethics committee approved the study under number 2.931.940.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}]}}